Icahn School of Medicine at Mount SinaiNew York, New York, United States
Disclosure(s): No financial relationships to disclose
161 - Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis
Thursday, October 17, 20242:15 PM – 2:30 PM US PT
